Earum Pharmaceuticals Ltd.
Snapshot View

110.05 +5.20 ▲5.0%

30 July 2021, 04:00:00 P.M.
Volume: 6,000

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website https://www.earumpharma.com
Financial Indicators
Market Cap 67.88 Cr.
Earnings per share (EPS) -0.08 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 117.83 Trailing Twelve Months Ending 2021-03
Book Value / Share 23.37 Trailing Twelve Months Ending 2021-03
Price to Book Value 4.71 Calculated using Price: 110.05
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.62 Cr. 6,167,910 Shares
FaceValue 10
Company Profile

Earum Pharmaceuticals

Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.

Business area of the company

The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.  Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+4.96%
1 Week
+27.37%
1 Month
+100.09%
3 Month
+62.44%
6 Month
+32.35%
1 Year
+52.64%
2 Year
+175.12%
5 Year
5 years 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83
Return on Capital Employed (%) 17.10 21.97 24.94 23.99 17.40
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11

Balance Sheet View Details

Particulars 5 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1 2 5 6 14
Non Curr. Liab. 0 1 2 3 1
Curr. Liab. 7 9 13 15 20
Minority Int.
Equity & Liab. 9 11 20 23 36
Non Curr. Assets 0 0 0 0 4
Curr. Assets 9 11 19 23 32
Misc. Exp. not W/O
Total Assets 9 11 20 23 36

Profit Loss View Details

Particulars 5 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 19 23 35 51 55
Other Income 0 0 0 0 2
Total Income 19 24 36 51 57
Total Expenditure -18 -23 -34 -47 -54
PBIDT 1 1 2 3 4
Interest 0 -1 -1 -1 -1
Depreciation 0 0 0 0 0
Taxation 0 0 0 -1 -1
Exceptional Items
PAT 0 0 1 2 2

Cash Flow View Details

Particulars 5 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3
Cash Fr. Inv. 0 0 0 0 -3
Cash Fr. Finan. 1 0 7 1 7
Net Change 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0

Shareholding Pattern View Details

5 Qtrs 2018-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%)
Promoter 100.00 70.04 70.04 70.04 70.04
Public 0.00 29.96 29.96 29.96 29.96
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Sat, 31 Jul 2021
Board Meeting Intimation for Intimation Of Board Meeting- Allotment ( Bonus Issue)
Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 inter alia to consider and approve
Dear Sir/Madam

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of Board of Directors of our Company is scheduled to be held on Wednesday August 11 2021 at the Corporate Office of the Company to transact the following businesses:

1. To consider and allot the Bonus Equity Shares of Rs. 10/- each in a ratio of Rs. 1:1 i.e. One Equity Shares of Rs. 10/- each for every One Equity Shares of Rs. 10/- each to the member eligible for such allotment as on Record Date i.e. August 10 2021

2. Any other business with the permission of Chair

Kindly take the note of the same and oblige.

Thanking You.
Thu, 29 Jul 2021
Intimation For Record Date For Issue Of Bonus Equity Shares
Dear Sir/Madam

With reference to the captioned subject and pursuant to SEBI LODR and applicable statutory provisions this is to inform you that the record date shall be Tuesday August 10 2021 to determine the name of shareholders entitled for Bonus equity shares in proportion of 1 (One) bonus equity share for every 1(One) fully paid-up equity share held.
In respect of the equity shares held in demat or electronic form the Bonus Shares will be
Credited into respective demat account of allottees through corporate actions as per details furnished by National Securities Depository Limited and Central Depository Services (India)Limited for this purpose.

The above disclosures are in compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI LODR) and statutory provisions.

Kindly take the same on your record and display on your website.

Thanking you.
Tue, 27 Jul 2021
Board Meeting Intimation for <BR> To Consider And Approve The Revised Audited Standalone Financial Results Of The Company For The Half Year And Year Ended On March 31 2021<BR> <BR>
Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2021 inter alia to consider and approve To consider and approve the revised audited Standalone Financial Results of the Company for the half year and year ended on March 31 2021

Technical Scans View Details

Fri, 30 Jul 2021
Stock Outperforming Benchmark Index in both 1 Week and 3 Month Stock Outperforming Benchmark Index in both 1 Week and 3 Month
Stock Outperforming Sectoral Index in both 1 Week and 3 Month Stock Outperforming Sectoral Index in both 1 Week and 3 Month
Increasing Relative Strength - Benchmark index Increasing Relative Strength - Benchmark index
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
Close Crossing 2 Year High Close Crossing 2 Year High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 156,272.01 1,420.90 +1.4%
Adani Transmission Ltd. 99,395.34 903.75 -4.1%
Sundram Fasteners Ltd. 16,089.53 765.70 +2.4%
Redington (India) Ltd. 12,783.63 327.30 +0.7%
MMTC Ltd. 7,567.50 50.45 -0.4%
Novartis India Ltd. 2,368.71 960.15 +2.2%
MSTC Ltd. 1,999.71 284.05 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 169.37 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 81.20 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 44.80 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 16.90 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 0.00 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 113.34 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 17.70 284.05 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 9.11 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 16.32 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 6.86 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 2.59 327.30 +0.7%
MMTC Ltd. Standalone 2020-12 7.49 50.45 -0.4%
Novartis India Ltd. Standalone 2021-03 3.33 960.15 +2.2%
MSTC Ltd. Consolidated 2021-03 3.58 284.05 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 4.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 0.09 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 4.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 0.00 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 0.55 284.05 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 22.81 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 17.02 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -20.23 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 1.36 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 23.14 284.05 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 10.89 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 21.81 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -2.16 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 4.73 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 22.93 284.05 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 26,304.71 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 438.25 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 1,231.40 284.05 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,420.90 +1.4%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 903.75 -4.1%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 765.70 +2.4%
Redington (India) Ltd. Consolidated 2021-03 786.61 327.30 +0.7%
MMTC Ltd. Standalone 2020-03 -220.48 50.45 -0.4%
Novartis India Ltd. Standalone 2020-03 10.08 960.15 +2.2%
MSTC Ltd. Consolidated 2020-03 99.71 284.05 -1.5%